Back to top
more

Avanos Medical (AVNS)

(Delayed Data from NYSE)

$23.02 USD

23.02
361,188

+0.53 (2.36%)

Updated Aug 8, 2024 04:00 PM ET

After-Market: $23.03 +0.01 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 42% (106 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Shockwave Medical (SWAV) Launches New IVL Catheter in U.S.

Shockwave Medical's (SWAV) latest U.S. launch is expected to serve a wider patient pool.

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

OPKO Health (OPK) to Develop EBV Vaccine With Latest Tie-Up

OPKO Health's (OPK) entry into a worldwide license and collaboration agreement with Merck is expected to aid in developing a vaccine against EBV.

Here's Why You Should Retain NextGen (NXGN) Stock for Now

NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.

QuidelOrtho's (QDEL) Rapid Antigen Test Gets De Novo FDA Approval

QuidelOrtho's (QDEL) receipt of the FDA's De Novo approval is expected to enable it to provide the test as an aid in the diagnosis of SARS-CoV-2 infections in symptomatic individuals.

Encompass Health's (EHC) 155th Hospital Opens in Wisconsin

The Rehabilitation Hospital of Western Wisconsin is Encompass Health's (EHC) first location in the state.

UnitedHealth (UNH) Plan in Indiana to Offer Pathways Program

UnitedHealth (UNH) expects the new Pathways for Aging program to serve around 100,000 people.

Brookdale Senior (BKD) February Weighted Average Occupancy Up

Brookdale Senior Living (BKD) witnesses 16 straight months of year-over-year increases in weighted average occupancy level.

Here's Why You Should Retain McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Dips

Orthofix (OFIX) reports impressive performance across the BGT and Global Orthopedics segment in the fourth quarter.

Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment

Nevro's (NVRO) Senza HFX iQ SCS system is expected to treat individual patients per their particular treatment requirements.

Here's Why You Should Retain Catalent (CTLT) Stock for Now

Catalent's (CTLT) product and service launches and a slew of strategic deals raise optimism about the stock.

Three Reasons to Add BD (BDX) Stock to Your Portfolio Now

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.

Here's Why You Should Retain Surmodics (SRDX) Stock for Now

Investors continue to be optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.

Walgreens Boots (WBA) Benefits From New Launches Amid FX Woes

Walgreens Boots' (WBA) comparable pharmacy sales decline, reflecting lower demand for COVID-19 services.

Humana (HUM) Ties Up To Offer Value-Based Care to MA Members

Humana (HUM) inks a 10-year collaboration with Aledade to ensure continued value-based primary care to its Medicare Advantage members from Aledade-backed physicians.

NextGen (NXGN) Behavioral Health Suite Adopted by Compass Health

NextGen's (NXGN) Behavioral Health Suite is expected to aid Compass Health in improving its workflow.

Should Value Investors Buy Avanos Medical (AVNS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SmileDirectClub (SDC) Q4 Earnings Beat, Gross Margin Down

SmileDirectClub (SDC) delivers an improved bottom line and cash flows in the fourth quarter despite a reduction in revenues.

Community Health (CYH) to Divest Two NC Hospitals for $320M

Community Health (CYH) expects the North Carolina hospitals' divestment to close at a later part of this year.

Humana (HUM), CD&R Backed Gentiva to Buy Assets From ProMedica

The acquisition is expected to boost Humana (HUM) and CD&R backed Gentiva's reach to over 500 locations.

Omnicell (OMCL) Q4 Earnings Beat Estimates, Margins Down

Omnicell (OMCL) delivers earnings and revenues in the fourth quarter exceeding the previously revised outlook amid macroeconomic challenges.

Acadia Healthcare (ACHC) Q4 Earnings Miss on Rising Costs

Acadia Healthcare's (ACHC) 2023 capital expenditure for expansion initiatives is predicted to stay between $350 million and $400 million.

Alcon (ALC) Q4 Earnings Match Estimates, Margins Contract

Alcon (ALC) reports impressive CER growth in net sales across all segments in the fourth quarter amid a challenging macroeconomic environment.